NCT06768671Phase 3Completed

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

Study sponsor: MoonLake Immunotherapeutics AG

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-28Actual
Enrollment · participants35Actual
Source updated2026-11-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 2 fields changed

Primary completion date changed

Before: 27 Mar 2026. After: 28 Sep 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source